Toronto, Canada

Daniel Letourneau


 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Letourneau

Introduction

Daniel Letourneau is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of radiotherapy, particularly through his innovative patents. With a total of 3 patents, Letourneau's work focuses on enhancing the quality assurance processes for MR-Linac devices.

Latest Patents

One of Letourneau's latest patents involves automating quality assurance testing for radiotherapy equipment, specifically MR-Linac devices. This patent outlines procedures that are agnostic to the manufacturer and vendor of the equipment. The disclosure includes a comprehensive process for performing validation procedures for the linear accelerator of the MR-Linac device. Additionally, it details methods for analyzing the quality of images produced by the MR imaging device of the MR-Linac. Furthermore, the patent combines the performance of validation procedures with the analysis of image quality, ensuring a robust quality assurance framework.

Career Highlights

Throughout his career, Daniel Letourneau has worked with prominent organizations such as Elekta, Inc. and the University Health Network. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of medical technology.

Collaborations

Letourneau has collaborated with esteemed colleagues, including Elaine Conneely and David Anthony Jaffray. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Daniel Letourneau's contributions to the field of radiotherapy through his patents and collaborations highlight his commitment to innovation and quality assurance in medical technology. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…